Lonza Optimized Protocol
Optimization Guideline
Filter:
The table below shows data for the cell type and Nucleofector™ Platform selected. Those data are either based on Lonza Optimized Protocols
or on results shared from customers who performed an optimization based on our guidelines. In case no data are shown for the selected Nucleofector™ Platform, please take a look at our
optimization strategy to get further guidance on how to easily determine optimal Nucleofection conditions yourself.
Categories:
Transfection
Authors:
Kouranova E, Forbes K, Zhao G, Warren J, Bartels A, Wu Y, Cui .
In:
Hum Gene Ther (2016) 27(69: 464-75
Categories:
Transfection
Authors:
Larcher T, Lafoux A, Tesson L, Remy S, Thepenier V, François V, Le Guiner C, Goubin H, Dutilleul M, Guigand L, Toumaniantz G, De Cian A, Boix C, Renaud JB, Cherel Y, Giovannangeli C, Concordet JP, Anegon I, Huchet C.
In:
PLoS ONE (2014) 9(10): e11037
Categories:
Transfection
Authors:
Lomonaco SL, Kahana S, Blass M, Brody Y, Okhrimenko H, Xiang C, Finniss S, Blumberg PM, Lee HK, Brodie C
In:
J Biol Chem (2008) 283(25): 17731-9
Categories:
Transfection
Authors:
Choi BH, Kim CG, Bae YS, Lim Y, Lee YH, Shin SY
In:
Cancer Res (2008) 68(5): 1369-77
Categories:
Transfection
Authors:
De Domenico I, Ward DM, di Patti MC, Jeong SY, David S, Musci G, Kaplan J
In:
EMBO J (2007) 26(12): 2823-31
Categories:
Transfection
Authors:
Kapic A, Helmbold H, Reimer R, Klotzsche O, Deppert W and Bohn W
In:
Cell Death Differ (2006) 13(2): 324-334
Categories:
Transfection
Authors:
Gresch O, Engel FB, Nesic D, Tran TT, England HM, Hickman ES, Korner I, Gan L, Chen S, Castro-Obregon S, Hammermann R, Wolf J, Muller-Hartmann H, Nix M, Siebenkotten G, Kraus G and Lun K
In:
Methods (2004) 33(2): 151-163
+ Show All